Home▸Articles▸Direct-to-Consumer Genomics Testing

Understanding DTC Pharmacogenomic Report Actionability Scores

A tool that quantifies the clinical significance of genetic test results for personalized medicine.

mysimulator teamUpdated June 2026≈ 4 min read▶ Open the simulation

What DTC Pharmacogenomic Report Actionability Scores Are

Pharmacogenomic (PGx) reports from direct-to-consumer (DTC) genetic tests provide insights into how an individual's genetics may affect their response to certain medications. An actionability score is a numerical value assigned to each PGx report result, indicating the clinical relevance of the information provided. This score helps healthcare providers and patients understand whether the genetic variant identified has significant implications for drug therapy.

For example, if a patient carries a genetic variant that significantly affects how they metabolize a specific medication, their actionability score would be high, suggesting that this information is highly relevant to their treatment plan.

How Actionability Scores Are Calculated

Actionability scores are typically calculated based on several factors, including the strength of evidence linking the genetic variant to drug response, the clinical utility of the information for patient care, and the potential impact on treatment outcomes. These scores often consider both the frequency of the variant in the population and its known effect on drug efficacy or toxicity.

For instance, a score might be higher if the genetic variant is common and has been extensively studied, leading to well-established guidelines for adjusting medication dosages.

live demo · related simulation● LIVE

Why Actionability Scores Matter

Actionability scores are crucial because they help prioritize which PGx results require immediate attention from healthcare providers. By focusing on the most clinically relevant information, these scores can guide personalized treatment decisions that may improve patient outcomes and reduce adverse drug reactions.

Moreover, actionability scores facilitate informed discussions between patients and their healthcare providers about the potential benefits and risks of different medications based on individual genetic profiles.

Real-World Examples

Consider a patient with a known genetic variant that affects cytochrome P450 enzymes, which are involved in metabolizing many drugs. If the actionability score is high for this variant, it indicates that the patient's metabolism of certain medications may be significantly altered, leading to either reduced efficacy or increased toxicity.

In another scenario, a patient might have a genetic variant with a low actionability score, meaning the information provided does not strongly influence their treatment plan. This can help healthcare providers focus on more critical PGx results and avoid unnecessary tests.

Frequently asked questions

How are actionability scores different from risk assessments?

Actionability scores focus specifically on the clinical relevance of genetic variants for drug therapy, whereas risk assessments might consider a broader range of health outcomes and factors beyond just pharmacogenomics.

Can patients use DTC PGx reports without consulting a healthcare provider?

While DTC PGx reports can provide valuable information, they should generally be interpreted in the context of clinical guidelines and discussions with a healthcare provider to ensure safe and effective drug therapy.

Are all genetic variants included in actionability scores equally important?

No, not all variants are equally important. Actionability scores take into account the strength of evidence for each variant's impact on drug response, ensuring that only the most clinically relevant information is highlighted.

How do healthcare providers use these scores in practice?

Healthcare providers can use actionability scores to prioritize which PGx results require immediate attention and to guide personalized treatment decisions. This helps ensure that patients receive the most appropriate medications based on their genetic profiles, potentially improving outcomes and reducing adverse reactions.

Try it live

Everything above runs in your browser — open DTC Pharmacogenomic Report Actionability Score and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open DTC Pharmacogenomic Report Actionability Score simulation

What did you find?

Add reproduction steps (optional)